Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.36 USD | +1.24% |
|
-8.34% | 0.00% |
06-24 | Kyverna Therapeutics, Inc.(NasdaqGS:KYTX) added to S&P Global BMI Index | CI |
06-20 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 317M | |
+21.85% | 46.44B | |
+38.65% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |
- Stock Market
- Equities
- KYTX Stock
- News Kyverna Therapeutics, Inc.
- Kyverna Therapeutics Gets FDA Investigational New Drug Application Clearance for KYV-101 to Treat Stiff-Person Syndrome